Skip to content
Recruiting

A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma

About this study

It is not known whether radiological assessments during follow up after surgery for high risk melanoma improve survival. Since radiological examinations are resource demanding, could inflict worry and cause irradiation exposure it is an important question to address. With the introduction of effective medical treatments for malignant melanoma patients, there is a tendency to introduce radiological assessments despite the lack of evidence.

Condition
Malignant Melanoma
Tested
CT or PET scans
Sponsor
Uppsala University

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 5

  • Minimum age: 18 years
  • Study condition: Malignant Melanoma
  • At least 18 years of age.
  • Radical surgery for Cutaneous Malignant Melanoma (CMM) stage IIb-c and III.
  • Sufficient renal function for i.v. contrast scannings.

Exclusion 7

  • The patient is assessed as unfit to receive treatment in the case of recurrence.
  • Life-expectancy less than 2 years due to concurrent disease (e.g., cardiac disease, terminal multiple sclerosis, liver cirrhosis).
  • Inability to provide informed consent or refusal to do so.
  • Inability to comply with the control or intense follow-up program.
  • Participation in other clinical trials interfering with the control-program.
  • Existing or previous malignancies within the past 5 years (except for in situ breast and cervical cancer, melanoma in situ and non-melanoma skin cancer).
  • Pregnancy or currently planned pregnancy.

Where

20 sites, 16 recruiting

Mälarsjukhuset Eskilstuna

Eskilstuna, Sweden

Recruiting

Falu lasarett

Falun, Sweden

Recruiting

Gävle sjukhus

Gävle, Sweden

Recruiting

Department of Surgery, Sahlgrenska University Hospital

Gothenburg, Sweden

Recruiting

Helsingborgs lasarett

Helsingborg, Sweden

Recruiting

Länssjukhuset Ryhov

Jönköping, Sweden

Recruiting

and 14 more sites on ClinicalTrials.gov

Contact

Potential match only. Final eligibility is determined by the study team.